Finance

Beta
Ask
Lists
137:FRA
Aldeyra Therapeutics Inc
€1.51
+2.72%
(+0.040) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 137...
Open
€1.47
High
€1.52
Low
€1.47
Mkt. cap
106.17M
Avg. vol.
101.00
Volume
0.00
52-wk high
€5.05
52-wk low
€1.05
No. of employees
7
Open
€1.47
High
€1.52
Low
€1.47
Mkt. cap
106.17M
Avg. vol.
101.00
Volume
0.00
52-wk high
€5.05
52-wk low
€1.05
No. of employees
7
News stories
From sources across the web
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees7
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitealdeyra.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.51M
5.43M
4.30M
2.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.66M
2.57M
2.36M
1.14M
Operating expense
10.17M
8.00M
6.67M
3.55M
Total operating expenses
10.17M
8.00M
6.67M
3.55M
Operating income
-10.17M
-8.00M
-6.67M
-3.55M
Other non operating income
-
-
-
-
EBT including unusual items
-9.77M
-7.69M
-6.46M
-3.45M
EBT excluding unusual items
-9.77M
-7.69M
-6.46M
-3.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.77M
-7.69M
-6.46M
-3.45M
Net profit margin
-
-
-
-
Earnings per share
-0.16
-0.13
-0.10
-0.06
Interest and investment income
872.04K
788.69K
681.64K
562.98K
Interest expense
-470.62K
-475.90K
-475.26K
-468.68K
Net interest expenses
401.42K
312.79K
206.38K
94.30K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.11M
-7.94M
-6.60M
-3.48M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer